Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2000
08/17/2000WO2000047768A1 Modulator of inflammation
08/17/2000WO2000047767A1 Oligonucleotide array and methods of use
08/17/2000WO2000047766A1 Method for detecting variant nucleotides using arms multiplex amplification
08/17/2000WO2000047765A1 Materials and methods relating to the detection of a cancer cell marker
08/17/2000WO2000047764A2 Test kit and method for quantitatively detecting genetically modified dna in foodstuff by means of fluorescence-coupled pcr
08/17/2000WO2000047762A2 Enriched central nervous system cell populations
08/17/2000WO2000047761A2 High-throughput toxicological testing using cultured organisms and cells
08/17/2000WO2000047760A2 Atm kinase modulation for screening and therapies
08/17/2000WO2000047752A2 Macular degeneration diagnostics and therapeutics
08/17/2000WO2000047750A2 Metalloproteases of the neprilysin family
08/17/2000WO2000047745A1 The ltr region of msrv-1 and the proteins it encodes, and probes and methods for detecting msrv-1 retrovirus
08/17/2000WO2000047739A2 Autoantigens for the diagnostic of endometriosis
08/17/2000WO2000047738A2 Human and mouse trek-1 potassium channel protein and their use
08/17/2000WO2000047734A1 Inhibiting formation of atherosclerotic lesions
08/17/2000WO2000047731A1 Protein having dna helicase activity, polynucleotide encoding the protein, antisense polynucleotide against the polynucleotide and antibody recognizing the protein
08/17/2000WO2000047723A2 Human diacylglycerol kinase beta (hdagk beta) proteins and nucleotide sequences encoding the same
08/17/2000WO2000047717A1 Avian pluripotent embryonic germ cell line
08/17/2000WO2000047622A2 Peptides with anti-angiogenic activity
08/17/2000WO2000047619A1 Therapeutics and diagnostics based on an il-1b mutation
08/17/2000WO2000047618A2 HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES
08/17/2000WO2000047615A2 Proteins related to neuronal regeneration and uses thereof
08/17/2000WO2000047612A2 Structure-based screening techniques for drug discovery
08/17/2000WO2000047602A1 33 human secreted proteins
08/17/2000WO2000047600A1 Photo-induced nucleic acid hybridization
08/17/2000WO2000047598A1 Method and apparatus for compound library preparation using optical modulator
08/17/2000WO2000047548A1 Improved compounds for protein binding
08/17/2000WO2000047317A1 Method for producing addressed ligand matrixes on a support
08/17/2000WO2000047236A1 Matrices for drug delivery and methods for making and using the same
08/17/2000WO2000047219A2 Methods and reagents for treating glucose metabolic disorders
08/17/2000WO2000038838A8 Apparatus and methods for efficient processing of biological samples on slides
08/17/2000WO2000034449A8 UDP-N- ACETYL GLUCOSAMINE: GALACTOSE-β1, 3-N- ACETYL GALACTOSAMINE- α-R/ N- ACETYL GLUCOSAMINE -β1, 3-N- ACETYL GALACTOSAMINE- α-R (GlcNAc TO GalNAc) β1,6-N- ACETYL GLUCOSAMINYL TRANSFERASE, C2/4GnT
08/17/2000WO2000031273A3 Process for oxidising terpenes
08/17/2000WO2000030590A3 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2
08/17/2000WO2000028080A3 Methods, software and apparati for identifying genomic regions harboring a gene associated with a detectable trait
08/17/2000WO2000024931A3 Detection of analytes
08/17/2000WO2000024766A3 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
08/17/2000WO2000023616A3 Method for the exponential amplification of molecular matrices
08/17/2000WO2000018912A3 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases
08/17/2000WO2000017643A9 A system for cell-based screening
08/17/2000WO2000016641A9 Interactions between genotype and diet in swine that prevent e coli associated intestinal disease
08/17/2000WO2000016089A9 Signal detection techniques for the detection of analytes
08/17/2000WO2000016062A9 Methods for determining the activity of complex mixtures
08/17/2000WO2000015816A9 Maize replication protein a
08/17/2000WO2000015784A3 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same
08/17/2000WO2000014268A9 Modulation of microbial metabolism and/or growth rate by plant growth hormones
08/17/2000WO2000014267A8 Biosensor
08/17/2000WO2000014230A9 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
08/17/2000WO2000013026A9 Energy transfer dyes
08/17/2000WO2000005393A3 A polynucleotide comprising a ubiquitous chromatin opening element (ucoe)
08/17/2000WO2000000639A3 Method for detecting of a compound that mimics, potentiates or inhibits the physiological effect of leptin
08/17/2000WO1999064594A3 Genes and gene expression products that are differentially regulated in prostate cancer
08/17/2000WO1999040226A3 Determination of a genotype of an amplification product at multiple allelic sites
08/17/2000DE19900638A1 Methode zur Isolierung von DNA aus biologischen Materialien Method for the isolation of DNA from biological materials
08/17/2000CA2716429A1 Udp-glucose modifiers
08/17/2000CA2364288A1 Enzyme-linked immuno-magnetic electrochemical biosensor
08/17/2000CA2362586A1 Biallelic markers derived from genomic regions carrying genes involved in arachidonic acid metabolism
08/17/2000CA2362541A1 Structure-based screening techniques for drug discovery
08/17/2000CA2362524A1 The ltr region of msrv-1 and the proteins it encodes, and probes and methods for detecting msrv-1 retrovirus
08/17/2000CA2361384A1 High throughput mass spectrometry
08/17/2000CA2361335A1 Inhibiting formation of atherosclerotic lesions
08/17/2000CA2361293A1 33 human secreted proteins
08/17/2000CA2361034A1 Proteins related to neuronal regeneration and uses thereof
08/17/2000CA2360324A1 Peptide yy (pyy) for inducing glucose responsiveness in pancreatic islets
08/17/2000CA2359800A1 Aptamers as reagents for high throughput screening
08/17/2000CA2359785A1 .beta.-secretase enzyme compositions and methods
08/17/2000CA2359757A1 Polymorphic markers of the lsr gene
08/17/2000CA2341348A1 Improved compounds for protein binding
08/16/2000EP1028319A2 Device and method for measuring HDL-cholesterol emplying precipitation on a solid-phase
08/16/2000EP1028165A1 Method for quantitatively determining bicarbonate ion in liquid and dry analysis device
08/16/2000EP1028124A2 Improved process for the synthesis of oligomeric compounds
08/16/2000EP1027890A2 Homer a new target of treating psychiatric disorders
08/16/2000EP1027607A1 Method for enhancing fluorescence
08/16/2000EP1027605A1 Method for detecting cryptosporidium parvum oocysts
08/16/2000EP1027604A1 Extended dynamic range assays
08/16/2000EP1027602A1 A method of determining the concentration of an analyte with the use of a bioelement and a device operating in accordance with the method
08/16/2000EP1027459A1 Telemedicine
08/16/2000EP1027458A2 Multiple sequential polynucleotide displacement reactions for signal amplification and processing
08/16/2000EP1027457A1 Reagents and methods useful for detecting diseases of the breast
08/16/2000EP1027456A1 Expression profiles in adult and fetal organs
08/16/2000EP1027455A2 Methods and compositions for targeting dna metabolic processes using aminoglycoside derivatives
08/16/2000EP1027454A1 Characterising polypeptides
08/16/2000EP1027450A1 Method of dna shuffling
08/16/2000EP1027444A1 Reagents and methods useful for detecting diseases of the breast
08/16/2000EP1027443A2 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
08/16/2000EP1027442A1 Svph1-26 dna and polypeptides
08/16/2000EP1027441A2 Murine dna molecules encoding polypeptides having kinase functions
08/16/2000EP1027435A2 Nucleic acid molecule encoding a (poly)peptide co-segregating in mutated form with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (apeced)
08/16/2000EP1027430A1 64 human secreted proteins
08/16/2000EP1027429A1 Jnk3 modulators and methods of use
08/16/2000EP1027424A1 Regulators of ucp3 gene expression
08/16/2000EP1027372A1 Methods, kits and compositions pertaining to linear beacons
08/16/2000EP1027370A2 A method for mapping the active sites bound by enzymes that covalently modify substrate molecules
08/16/2000EP1027365A2 Antitumour uridine analogues
08/16/2000EP1027364A2 Pyrimidine derivatives for labeled binding partners
08/16/2000EP1027123A1 Fraction collection system and method
08/16/2000EP1027121A1 Improved liquid chromatographic media for polynucleotide separation
08/16/2000EP1027059A2 Enhancement of morphogen activity
08/16/2000EP1026988A1 Novel fluorescent reporter molecules and their applications including assays for caspases
08/16/2000EP1026987A1 Spectral bio-imaging of the eye
08/16/2000EP0865502A4 A fluorescence-based screening method for identifying ligands
1 ... 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 ... 3003